Fortrea Holdings $FTRE spun off from LabCorp with bold promises of growth and profitability—but insiders now face a lawsuit over alleged securities fraud. In this episode of Bulls & Betrayal, we dive into missed earnings, crumbling contract pipelines, and insider stock sales—all while the company talked up tech upgrades and margin magic. Perfect for investors, biotech watchers, and Wall Street accountability junkies.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Hit ZLK.com for more on the case and follow us for the next corporate faceplant.

Civitas Resources $CIVI promised strong production and growth—but behind the scenes, well counts dropped, debt ballooned, and executives vanished. In this episode of Bulls & Betrayal, we expose how upbeat forecasts masked real operational decline and why investors are now suing over sudden stock losses and surprise layoffs. If you’re into energy markets, corporate accountability, or just love a good Wall Street takedown, this one’s for you.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Check out ZLK.com to learn more or join the class action.

Biotech hopeful Iovance $IOVA promised a blockbuster launch of its cancer drug Amtagvi—forecasting nearly half a billion in revenue. But when reality hit, it came crashing down. In this episode of Bulls & Betrayal, we uncover how lofty projections, slow treatment rollout, and alleged internal knowledge of infrastructure issues led to a brutal 45% stock plunge. Ideal for investors, healthcare analysts, and corporate truth-seekers. Expect biotech drama, class action insights, and sharp market analysis.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Learn more or join the case at ZLK.com

Red Cat Holdings $RCAT soared on drone hype, military contracts, and big promises—but now it’s facing investor lawsuits, insider sell-offs, and claims of massive exaggeration. In this episode of Bulls & Betrayal, we unpack the alleged deception behind “thousands of drones,” a $260M contract fantasy, and a reality crash that clipped investor wings. Ideal for investors, military-tech watchers, and truth seekers. Expect sharp storytelling, legal drama, and behind-the-scenes breakdowns.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Get the full story and join the case at ZLK.com

DoubleVerify $DV claimed to protect brands from bot traffic—but now it’s accused of billing for ads shown to obvious bots and losing major clients. In this episode of Bulls & Betrayal, we dive into a digital deception unraveling across Wall Street. Perfect for adtech skeptics, investors, and truth-hunters who want the real story behind stock drops and lawsuits. Expect insider analysis, sharp wit, and zero fluff.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Visit ZLKcom to join the class action and follow for more financial fraud breakdowns.

Krispy Kreme $DNUT said investors would be "rolling in the dough"—but now it’s lawsuits and losses. This episode of Bulls & Betrayal dives into the frosted fiasco behind the $33 million miss and tanking stock. Perfect for retail investors, finance sleuths, and anyone craving corporate accountability. Expect sharp banter, deep dives, and a dash of comedy.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Visit ZLK.com to learn more about the class action, and follow us for more stock scandal exposés.

When $CAR Avis Budget Group accelerated its fleet rotation strategy, it didn’t just switch out cars—it wiped nearly $2 billion off the books in one quarter. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we break down the class action lawsuit accusing Avis of misleading investors by hiding the true financial impact of its fleet decisions. Perfect for investors, finance pros, and corporate accountability watchers. Expect deep dives and sharp analysis.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

Learn more at ZLK.com.

Organon $OGN promised investors dividends were priority number one—then slashed payouts by over 70%. In this episode of Bulls & Betrayal: Holding Wall Street Accountable, we dig into the lawsuit claiming Organon misled shareholders while quietly shifting gears to pay down debt. If you’re into dividend stocks, corporate trust, or securities law drama, this episode’s for you. Expect sharp commentary and deep dives.

We’re not lawyers or accountants, so don’t take this as legal or financial advice.

More info at ZLK.com.